Pentavalent rotavirus vaccine bovine reassortant - Serum Institute of India
Alternative Names: BRV-PV; LBRV-PV; Live attenuated bovine-human reassortant rotavirus vaccine; Rota-V-Aid™; ROTASIIL®Latest Information Update: 15 Sep 2021
At a glance
- Originator Serum Institute of India
- Developer Pharm Aid; Serum Institute of India
- Class Rotavirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Rotavirus infections
Most Recent Events
- 22 Feb 2019 Phase-III clinical trials in Rotavirus infections (In infants, Prevention) in Russia (PO) (NCT05032391)
- 28 Sep 2018 Launched for Rotavirus infections (In infants, Prevention) in India (PO) before September 2018
- 25 Jun 2018 Serum Institute of India completes a phase II/III trial in Rotavirus infections (Rotavirus gastroenteritis) (In volunteers, In infants, Prevention) in India (PO) (NCT03474055)